Cargando…

Pelvic Pain in Transgender People Using Testosterone Therapy

PURPOSE: This descriptive study aimed to assess the characteristics of pelvic pain and explore predictive factors for pelvic pain in transgender (trans) individuals using testosterone therapy. METHODS: An online cross-sectional survey was open between August 28, 2020, and December 31, 2020, to trans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zwickl, Sav, Burchill, Laura, Wong, Alex Fang Qi, Leemaqz, Shalem Y., Cook, Teddy, Angus, Lachlan M., Eshin, Kalen, Elder, Charlotte V., Grover, Sonia R., Zajac, Jeffrey D., Cheung, Ada S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079239/ https://www.ncbi.nlm.nih.gov/pubmed/36603056 http://dx.doi.org/10.1089/lgbt.2022.0187

Ejemplares similares

The impact of the first three months of the COVID-19 pandemic on the Australian trans community
por: Zwickl, Sav, et al.
Publicado: (2021)

Factors associated with suicide attempts among Australian transgender adults
por: Zwickl, Sav, et al.
Publicado: (2021)

Correction to: Factors associated with suicide attempts among Australian transgender adults
por: Zwickl, Sav, et al.
Publicado: (2021)

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
por: Angus, Lachlan, et al.
Publicado: (2019)

Testosterone concentrations and prescription patterns of 1% testosterone gel in transgender and gender diverse individuals
por: Nolan, Brendan J., et al.
Publicado: (2022)

Early Access to Testosterone Therapy in Transgender and Gender-Diverse Adults Seeking Masculinization: A Randomized Clinical Trial
por: Nolan, Brendan J., et al.
Publicado: (2023)

OR31-04 Testosterone Therapy On Gender Dysphoria, Depression, And Suicidality In Transgender And Gender Diverse Individuals Seeking Masculinisation: A Randomised Controlled Trial
por: Nolan, Brendan J, et al.
Publicado: (2023)

Approach to Interpreting Common Laboratory Pathology Tests in Transgender Individuals
por: Cheung, Ada S, et al.
Publicado: (2020)

The Health and Well-Being of Transgender Australians: A National Community Survey
por: Bretherton, Ingrid, et al.
Publicado: (2021)

SAT413 Feminising Gender Affirming Hormone Therapy Prolongs QTc Interval
por: Angus, Lachlan, et al.
Publicado: (2023)

Insulin resistance in transgender individuals correlates with android fat mass
por: Bretherton, Ingrid, et al.
Publicado: (2021)

Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study
por: Foster Skewis, Lucas, et al.
Publicado: (2021)

Sociodemographic and Clinical Characteristics of Transgender Adults in Australia
por: Cheung, Ada S., et al.
Publicado: (2018)

Bone Microarchitecture in Transgender Adults: A Cross‐Sectional Study
por: Bretherton, Ingrid, et al.
Publicado: (2022)

Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study
por: Nolan, Brendan J, et al.
Publicado: (2022)

SUN-046 Prevalence of Polycythaemia with Different Formulations of Testosterone Therapy in Transmasculine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020)

LBODP089 Effects Of Low-dose Oral Micronised Progesterone On Sleep, Psychological Distress And Breast Development In Transgender Individuals Undergoing Feminising Hormone Therapy: A Prospective Controlled Study
por: Nolan, Brendan J, et al.
Publicado: (2022)

Pelvic pain in transmasculine adolescents receiving testosterone therapy
por: Moussaoui, Dehlia, et al.
Publicado: (2022)

Health Needs of Trans and Gender Diverse Adults in Australia: A Qualitative Analysis of a National Community Survey
por: Zwickl, Sav, et al.
Publicado: (2019)

Uncovering the effects of gender affirming hormone therapy on skeletal muscle and epigenetics: protocol for a prospective matched cohort study in transgender individuals (the GAME study)
por: Jones, Patrice R, et al.
Publicado: (2022)

The Effects of Testosterone on the Brain of Transgender Men
por: Zubiaurre-Elorza, Leire, et al.
Publicado: (2021)

Recommendations for the Use of Testosterone in Male Transgender
por: Costa, Laura Bregieiro Fernandes, et al.
Publicado: (2018)

Vestibulovaginal Sclerosis in a Transgender Man on Testosterone
por: O'Sullivan, Clare, et al.
Publicado: (2020)

Selective Estrogen Receptor Modulators: A Potential Option For Non-Binary Gender-Affirming Hormonal Care?
por: Xu, Jane Y., et al.
Publicado: (2021)

Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review
por: Spanos, Cassandra, et al.
Publicado: (2020)

Feminizing Hormone Therapy Prescription Patterns and Cardiovascular Risk Factors in Aging Transgender Individuals in Australia
por: Balcerek, Matthew I., et al.
Publicado: (2021)

Testosterone therapy and breast histopathological features in transgender individuals
por: Baker, Gabrielle M, et al.
Publicado: (2020)

Fertility preservation in transgender men without discontinuation of testosterone
por: Stark, Brett A., et al.
Publicado: (2022)

Testosterone therapy masculinizes speech and gender presentation in transgender men
por: Hodges-Simeon, Carolyn R., et al.
Publicado: (2021)

FRI323 Prolactinoma Recurrence With Testosterone Treatment In Transgender Male
por: Arnouk, Nelly, et al.
Publicado: (2023)

Effects of testosterone treatment on hypothalamic neuroplasticity in female-to-male transgender individuals
por: Kranz, Georg S., et al.
Publicado: (2017)

Breast Cancer Development in a Transgender Male Receiving Testosterone Therapy
por: Barghouthi, Nadia, et al.
Publicado: (2018)

Angiofibroma stimulation in a transgender person receiving gender-affirming testosterone
por: Bubley, Jeffrey A., et al.
Publicado: (2020)

Effects of testosterone treatment on transgender males: A single-institution study
por: Korpaisarn, Sira, et al.
Publicado: (2021)

Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
por: Shankara Narayana, Nandini, et al.
Publicado: (2021)

Treating Acne in Transgender Persons Receiving Testosterone: A Practical Guide
por: Radi, Rakan, et al.
Publicado: (2022)

Acne fulminans in a transgender boy after an increase in testosterone dosage
por: Lee, Gayin, et al.
Publicado: (2022)

Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy
por: Cunha, Flávia Siqueira, et al.
Publicado: (2023)

Two Transgender Men Receiving Subdermal Testosterone Pellets for Gender Affirmation
por: Wolf Pulsiano, Sune L., et al.
Publicado: (2023)

Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy
por: Nolan, Brendan J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ksu7b3bt23da9frg7f7jn7nsk8